Nandini Molden
Overview
Explore the profile of Nandini Molden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
12
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guan X, Hu R, Choi Y, Srivats S, Nabet B, Silva J, et al.
Nature
. 2024 Aug;
633(8030):E1.
PMID: 39164390
No abstract available.
2.
Guan X, Hu R, Choi Y, Srivats S, Nabet B, Silva J, et al.
Nature
. 2024 May;
630(8016):E9.
PMID: 38816613
No abstract available.
3.
Guan X, Hu R, Choi Y, Srivats S, Nabet B, Silva J, et al.
Nature
. 2024 Mar;
627(8005):E11.
PMID: 38480897
No abstract available.
4.
Guan X, Hu R, Choi Y, Srivats S, Nabet B, Silva J, et al.
Nature
. 2024 Feb;
627(8004):646-655.
PMID: 38418879
Tiragolumab, an anti-TIGIT antibody with an active IgG1κ Fc, demonstrated improved outcomes in the phase 2 CITYSCAPE trial (ClinicalTrials.gov: NCT03563716 ) when combined with atezolizumab (anti-PD-L1) versus atezolizumab alone. However,...